Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS3701772 A
Publication typeGrant
Publication dateOct 31, 1972
Filing dateJun 1, 1970
Priority dateJun 12, 1969
Also published asCA931141A1
Publication numberUS 3701772 A, US 3701772A, US-A-3701772, US3701772 A, US3701772A
InventorsMorozumi Manami, Noda Yutaka, Suzuki Morio, Tamura Kiminori, Yoshino Hiroshi
Original AssigneeYamasa Shoyu Kk
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Production of nucleotide anhydrides
US 3701772 A
Abstract  available in
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

United States Patent PRODUCTION OF NUCLEOTIDE ANHYDRIDES Kiminori Tamura, Manami Morozumi, Yutaka Noda, Morio Suzuki, and Hiroshi Yoshino, Choshi-shi, Japan, assignors to Yamasa Shoyu Kabushiki Kaisha, Araoi, Choshi-shi, Chiba-ken, Japan No Drawing. Filed June 1, 1970, Ser. No. 42,579 Claims priority, application Japan, June 12, 1969, 44/ 45,786 Int. Cl. C07d- 51/50 US. Cl. 260-211.5 R 4 Claims ABSTRACT OF THE DISCLOSURE Nucleotide anhydrides can be synthesized, in each case, by a single-step process by causing a nucleoside-S'-monophosphate and diphenyl phosphorochloridate or tetraphenyl pyrophosphate to react in a suitable solvent and in the presence of an alkylamine and then adding to the resulting process materials alkylammoniurn salt of an acid dissolved in pyridine or one of its derivatives.

BACKGROUND OF THE INVENTION This invention relates generally to nucleotide anhydrides and production thereof and more particularly to a new and advanced process for producing nucleotide anhydrides by a one-step synthesis in a short time and in an economical manner.

The term nucleotide anhydride is herein used to designate an anhydride of nucleoside-5'-monophosphate and an acid whose acidity is weaker than diphenylphosphate. The anhydrides can be represented by the following general formula and consist of the compounds indicated in Table 1.

These nucleotide anhydrides are very important substances for the metabolism within living organisms, and

pharmaceutical and biochemical demand thereof is recently increasing.

For example, CDP-choline is effective for treatment of external head injuries, coma due to external injury 3,701,772 Patented Oct. 31, 1972 to the brain, etc. Trisodium inosine-5'-triphosphate (ITP-Na and trisodium thymidine-S'-triphosphate (TIP-Na are present within muscles and are valuable reagents for research on metabolism within living organisms. Adenosine triphosphate (ATP) is used for the circulation, particularly peripheral vascular disturbances, edema, beri-beri, and muscular fatigue and for the treatment of myositis (myitis, sarcitis), myasthenia, rheumatosis, arthritis, neuralgia, and other similar ailments.

Flavine adenine dinucleotide (FAD) is used as a medicine in the treatment of hepatic disturbances, trophopathy in pregnant women and lactating (breast-feeding) women, and toxicosis (toxinosis, toxipathy) such as alcohol damage and nicotinism. In addition, disodium uridine-S'-diphosphoglucose (UDPG-Na is of physiological value, and CDP-ethanolamine can be used as one kind of nucleotide coenzyme. Moreover, uridylyl sulfate, adenosine-S-2,4-dinitrophenyl phosphate, adenyl-5'-yl carbobenzy oxyglycine, and other nucleotide anhydrides are highly promising for future development and application as medicines and biochemical reagents.

Among various methods so far established for synthesizing these nucleotide anhydrides, the anion-exchange method is considered at present to be the most advantageous. The anion-exchange method comprises the following two steps. The first step is reaction of a nucleoside- 5'-monophosphate with tetraphenyl pyrophosphate or diphenyl phosphorochloridate in the presence of a tertiary base in dioxane or a mixture of dioxane and dimethyl formamide.

The reaction product is P -nucleoside-5-P -diphenyl pyrophosphate. The second step is reaction of purified P -nucleoside-5'-P -diphenyl pyrophosphate with an acid (whose acidity is weaker than diphenyl phosphate) to produce a nucleotide anhydride. The second reaction is based on the transition elfect of pyridine. Various nucleoside-S-monophosphates and acids can be combined arbitrarily by the anion exchange method to prepare various nucleotide anhydrides.

In this case, the purification of the intermediate product obtained by the first reaction is accomplished by concentrating the reaction mixture under reduced pressure to remove the solvent, adding ethyl ether to the resulting residue to precipitate the compound, letting the process material stand at 0 C. for 30 to 60 minutes, and removing the ether by decantation. However, since this intermediate material is unstable when exposed to moisture and heat, it is necessary to carry out the concentration under an anhydrous condition, at a low temperature, and in a high vacuum. Furthermore, an extremely large quantity of ethyl ether is required for precipitation, giving rise to great danger for a large scale operation. Thus the method is industrially disadvantageous. Moreover, in the process for isolation of the intermediate material, its significant loss is unavoidable.

Furthermore, water or ethyl ether admixed with the intermediate material obtained by precipitation markedly inhibits the second reaction and lowers the yield. Accordingly, it is disadvantageously necessary to resort to a process step of dissolving the precipitate in dioxane and concentrating the resulting solution under reduced pressure to romve these liquids by azeotropy.

Thus, the above described known method requires two stages of reaction, and the operation for isolating the intermediate material, moreover, is complicated and requires a long time and complicated production equipment. Furthermore, a large quantity of the solvent is necessary, and a considerable amount of the intermediate material is lost.

On account of these difiiculties this method is not suitable for industrial production.

3 SUMMARY OF THE INVENTION It is an object of the present invention to overcome the above described difficulties by utilizing certain findings we have made and thereby to provide a new advanced process for synthesizing nucleotide anhydrides whereby the reaction can be completed in a short time in one step by a simple operation without isolation of the intermediate materials.

We have found that a nucleotide anhydride can be synthesized in a single operation by causing a nucleoside-'- monophosphate and diphenyl phosphochloridate or tetraphenyl pyrophosphate to react in a suitable solvent and in the presence of an amine and then adding thereto an acid which .is weaker than diphenyl phosphate dissolved in pyridine or one of its derivatives.

According to the present invention, briefly summarized, there is provided a process for synthesizing nucleotide anhydrides wherein diphenyl phosphorochloridate or tetraphenyl pyrophosphate is added to an alkyl-ammonium saltof a nucleoside-S'-monophosphate in dioxane, N,N- dimethylformamide or N,N-dirnethylac'etamide and in the presence of an alkylamine, and, to the resulting process materials, a solution in pyridine of an alkalammonium salt of an acid to be condensed with the 5-phosphate part of the desired nucleotide.

The nature, details, and utility of the invention will be more clearly apparent from the following detiled description beginning with general considerations and concluding with specificexamples of practice illustrating preferred embodiments of the invention.

DETAILED DESCRIPTION A nucleoside-S'-monophosphate is generally used in the form of an alkylammonium salt in order to facilitate dissolution thereof in a reaction solvent. Particularly in consideration of solubility in the solvent, use o-f a salt of a trialkylamine or quarternary ammonium hydroxide (for example, tri-n-buthylamine, tri-n-octylamine, methyl-trin-butylammonium hydroxide, or methyl-tri-n-octylammonium hydroxide) is recommended.

Depending on the molar ratio between the nucleoside- 5'-monophosphate and alkylamine base in condensation, the mono (alkylarnmonium) salt and the di alkylammonium) salt may be obtained.

While either kind of salt can be used, the mono (alkylammonium) salt is principally used because of its reactivity.

In the present invention, the following nucleotides can be employed as one of starting materials:

Natural nucleotides such as 5'-cytidylic acid, 5'-deoxyadenylic acid, 5'-deoxyinosinic acid, 5'-deoxyguanylic acid, 5'-deoxycytidylic acid, 5'-thymidylic acid, and adenosine (2,3'-cyclic phosphate) 5'-phosphate and unnaturalnucleotides such as 2-methyl-thio-5-inosinic acid etc.

Any (reaction) solvent, whichv dissolves alkylammonium. salts of nuc1eoside-5'-phosphate and does not inhibit the reaction, can be employed in this invention. Examples of. such reaction solvents We have found to be suitable are N,N-dimethyl-.formamide, N,N-dimethylacetamide, and dioxane. While the minimum quantity of the solvent to be used is 5 times (in moles) that of the nucleoside-5'- phosphate, a preferable range is from to 50 times (in moles).

The above three solvents can be used not only alone, respectively, but also as a mixture of two or three thereof. In addition, in order, to increase the solubility of the reaction reagents, tetrahydrofuran, n-hexane, benzene, toluene, ethyl acetate, acetone, or chloroform can be added to the solvent to an extent that the reaction is not inhibited. The limit to the quantity be added is 2 to 3 times by volume that of the reaction solvent, and equal volume or less is preferable.

Diphenyl phosphorochloridate or tetraphenylpyrophosphate should be used so that its molar ratio to nucleoside- 5-phosphate is 1-2, preferentially 1-1.5.

Examples of alkylamine which is added as a reaction stabilizer are trin-n-ethylarnine, tri-n-ethylamine, tri-noctylamine, N-methylpiperidine, and diethylaniline. The stabilizer should be employed in an amount more than 0.5 mole, preferentially 1.2-2 moles, per one molar of the nucleoside-5'-phosphate.

After the reaction of nucleoside5-phosphate with diphenyl phosphorochloridate or tetraphenylpyrophosphate, a desired acid dissolved in pyridine or its derivative is directly added to the reaction mixture, where the reaction forming nucleotide anhydride from the nucleoside- 5'-monophosphate and the acid can be observed. The added acid should be a weaker acid than diphenyl phosphate. An acid whose acidity is stronger than that of diphenyl phosphate failed to form an acid anhydride with nucleoside-5-phosphate.

Examples of an acid weaker than diphenyl phosphate are: Anhydrous sulfuric acid, phosphates such as orthophosphate, pyrophosphate, and triphosphate; sugar phosphates such as glucose-l-phosphate, mannose-l-phosphate, and galactose-l-phosphate; carboxylic acids such as acetic acid, and propionic acid, carbobenzyloxy amines; peptides; phenols such as 2,4-dinitrophenol; nucleosides; and acid constitutents of coenzymes (for example, panthethin-4', 4'-bisphosphate, flavine monoculeotide, phenyl phosphate, choline phosphate, and nicotinamide phosphate).

In consideration of the solubility of the acid in an organic solvent, the acid is ordinarily added in the form of a salt of an alkylamine as, for example, tri-n-butylamine or tri-n-octylamine.

The acid should be used in an amount of more than one mole, preferentially 1-2 moles, per one molar of the nucleoside-5-phosphate.

Substances Which dissolve in pyridine with difficulty, such as flavine nucleotide, is dissolved in another solvent such as a formamide before mixing with pyridine.

It is essential to add pyridine or its derivative together with the acid simultaneously: The reaction of the acid with P -nucleoside-5'-P -diphenyl' pyrophosphate is regarded as an anion exchange reaction Where diphenyl phosphate (a strong acid) moiety of the latter compound is replaced by the weak acid. Pyridine or its derivatives are essential for this anion exchange reaction.

This is the reason why pyridine or its derivative should be added together with the acid.

In addition to pyridine that is used satisfactorily, several pyridine derivatives such as picoline, lutidine, and cholidine can also be used. 2-50 moles, particularly 5-30 moles, of pyridine or its derivative per 1 mole of the nucleotide gives a good yield.

The reactions in the process according to the invention are generally completed in a relatively short time, although the time depends on the kind and quantity of the solvent used and the temperature.

P -nucleoside-5'-P -diphenyl pyrophosphate is usually synthesized almost immediately after mixing nucleoside- 5-phosphate and diphenyl phosphorochloridate or tetraphenyl pyrophosphate under the conditions described previously. Therefore, the acid dissolved in pyridine or its derivative can be added to the reaction mixture almost immediately after mixing nucleoside5'-phosphate and diphenylphosphorochloridate or tetraphenyl pyrophosphate. The anion exchange reaction is completed in a few minutes to a few hours, in a high yield, with formation of only small amounts of by-products.

The anion exchange reaction can also be carried out a few minutes to a few hours after mixing nucleoside-5'- phosphate and diphenyl phosphorochloridate or tetraphenyl pyrophate.

It is surprising that the nucleotide anhydride can be synthesized directly in one vessel containing a complicated solvent system where several materials are added successively. Furthermore, the synthesis of the nucleotide anhydride proceeds rapidly in a high yield, with formation of only small amounts of by-products.

The inventors discovered this surprising fact for the first time. The present invention, based on this new discovery, thus establishes an economical process for synthesizing nucleotide anhydrides which is a superior, as will be indicated hereinafter, to the known method mentioned hereinbefore.

The nucleotide anhydrides produced by the process of the invention are purified by a combination of processes such as ion exchange resin column chromatography, and precipitation process with an organic solvent and/or other precipitants. The purified products were identified with respective nucleotide anhydrides by means of paper chromatography with several solvents, and physical, chemical and enzymatic analyses.

In order to indicate still more fully the nature and utility of the present invention, the following specific examples of practice constituting preferred embodiments of the invention and results are set forth, it being understood that these examples are presented as illustrative only and that they are not intended to limit the scope of the invention.

Example 1.Trisodium cytidine-'-diphosphate (CDP a) To one mole of mono (methyl tri-in-butylammonium)- 5'-cytidylate, 1,500 mol. of N,N-dimethylacetamide was added, and then 250 ml. of diphenyl phosphorochloridate was added.

The mixture was agitated for 5 minutes to dissolve the materials. 500 ml. of tri-n-butylamine and 2 l. of dioxane were then added to the batch.

After stirring for 5 minutes, 2 l. of pyridine containing 2 moles of mono (tri-n-butylammonium) phosphate was added to the batch.

After agitation, the mixture was left standing for one hour.

Upon completion of the reaction, the reaction mixture was concentrated in vacuo, added with 7 l. of water, then extracted with one litre" of benzene.

The water layer is diluted to 50 1., and applied to an anion exchange resin Duolite A101D (Cl type, 101.) column. Cytidine-5'-diphosphate was eluted from the column with 0.1 N hydrochloride, and crystallized as trisodium salt (387 grammes (g.) (11.0 percent moisture)). Yield 73.5 percent.

Molar ratio of the components is indicated in Table 2:

Example 2.Trisodium inosine-5'-triphosphate (ITP Na To 200 millimoles of mono (tri-n-butylammoniurn) 5'-inosinate, 120 ml. of N,N-dimethyl acetamide and mixture of 250 millimoles of tetraphenylpyrophosphate, 100 ml. of tri-n-butylamine, and 600 ml. of dioxane were added successively.

After agitating 200 ml. of pyridine containing 400 millimoles of di (tri-n-butylammonium) pyrophosphate was then added to the batch.

The mixture was then left standing for 40 minutes synthesized inosine 5'-triphosphate was isolated from the reaction mixture by means of anion-exchange resin Duolite A101D (Cl type, 10 litres) column chromatography, and obtained amorphous powder as trisodium salt. (107.9 g. (10.3 percent moisture content)) Yield, 84.3 percent.

Molar ratio of the components is indicated in Table 3.

TABLE 3 Molar ratio Inosine Total P tfifiiiiiitifiifisiijiji i133 3135 Example 3.-Trisodium thymidine-5'-triphosphate (TTP Na To 10 millimoles of mono (tri-n-butylammonium)-5'- thymidylate, 5 ml. of N,N-dimethylformamide and mixture of 2.3 ml. of diphenylphosphorochloridate, 5 ml. of tri-n-butylamine, and 20 ml. of dioxane were added successively, after agitating ml. of pyridine containing 20 millimoles of di (tri-n-butylammonium) pyrophosphate was added to the batch. Then, after 30 minutes, thymidine-5-triphosphate was isolated from the reaction mixture as usual. The yield was 79.7 percent.

Example 4.-Disodium uridine-5'-diphosphoglucose (UDPG Na l0 millimoles of mono (tri-n-butylammonium) 5-uridylate was dissolved in 5 ml. of N,N-dimethylformamine, and 5 m1. of dioxane, 6 ml. of tri-n-butylamine, and 2.3 ml. of diphenyl phosphorochloridate were added to the resulting solution.

After 10 minutes 15 ml. of pyridine containing 12 millimoles of mono (tri-n-butylamr nonium) glucose-l-phosphate was added to the mixture.

After allowing to stand for two hours, the solvent was removed under reduced pressure.

The remaining substances were dissolved in water and applied to anion exchange resin Dowex 1 X8 (Cl column (100 ml.). Uridine-5-diphosphoglucose was eluted from the column as usual, and obtained amorphous powder as disodium salt (4.12 g.). Yield, 67.5 percent.

Molar ratio of the components is indicated in Table 4.

In addition 98.6 percent of the preparation was dehydrogenized by the action of UDPG dehydrogenase.

Example 5 .Adenosine-5-diphosphoglucose (ADPG) To one millimole of mono (methyl-tri-n-butylammonium) 5'-adenylate, 1 ml. of N,N-dimethy1 acetamide, 0.22 ml., of dephenyl phosphorochloridate 1 ml. of dioxane, and 0.5 ml. of tri-n-butylamine were added successively.

After 30 minutes, 3 ml. of pyridine containing 1.5 millimoles of mono (tri-n-butylammoniurn) glucose-l-phosphate was added to the mixture. During one hour reaction, adenosine-5'-diphosphoglucose was synthesized in a yield of 81.5 percent.

Example 6.Flavine-adenine-dinucleotide (FAD) One millimole of mono (tri-n-octylammonium) 5'- adenylate was dissolved in 1 ml. of N,N-dimethyl acetamide, and to the resulting solution, 0.25 ml. of diphenyl phosphorochloridate 2 ml. of dioxane, and 0.5 ml. of trin-butylamine were added.

Then 2 ml. of formamide containing 1.8 millimoles of a mono (methyl-tri-n-butylammonium) salt of flavine mononucleotide and 4 ml. of pyridine was added to the mixture. During 1.5 hours reaction, flavine-adenine-dinucleotide was synthesized in a yield of 78.3 percent.

Example 7.CDP-ethanolamine Two millimoles of mono (methyl tri n octylammonium) 5-cytidylate was dissolved in 2 ml. of N,N-dirnethyl formamide, and to resulting solution, 0.5 ml. of diphenyl phosphorochloridate, 1 ml. of tri-n-butylamine, and 15 ml. of dioxane were added, the resulting solution and then being mixed.

5 ml. of pyridine containing 3 millimoles of mono (methyl-tri-n-butylammonium) salt of o-phosphoethanolamine was then added to the mixture. During 30 minutes raction, CDP ethanolamine, was synthesized in a yield of 52.7 percent.

Example 8.-Uridylyl sulfate 10 millimoles of mono (tri-n-octylammonium) 5'-uridylate was dissolved in 20 ml. of dioxane, and to the resulting solution, 2.5 ml. of diphenyl phosphorochloridate and 2.1 ml. of triethylamine were added.

After the resulting batch was left standing for 5 minutes at room temperature, 20 millimoles of tri-n-butylammonium sulfate and 5 ml. of pyridine were added to the mixture.

During one hours reaction uridylyl sulfate was synthe sized in a yield of 40 percent.

Example 9.-Adenosine-5'-2,4-dinitrophenyl-phosphate To 1 millimole of mono (methyl-tri-n-butylarnmonium) 5'-adenylate, 2 ml. of N,N-dimethyl acetamide was added, and then 0.25 ml. of diphenyl phosphorochloridate and 0.6 ml. of tri-n-butylamine were added after allowing it to stand at room temperature for one hour, 2 ml. of pyridine containing a solution of 2 millimoles of 2,4- dinitrophenol was added to the mixture. During 2 hours reaction at C., adenosine-S'-2,4-dinitrophenol phosphate synthesized in a yield of 91 percent.

Example 10.Adenyl-'-yl-carbobenzyl oxyglycine To 1 millimole of mono (tri-n-octylammonium) 5- adenylate, 2 m1. of N,N-dimethy1 acetamide was added, after. agitation a mixture of 0.25 ml. of diphenyl phosphorochloridate, 4 ml. of dioxane, and 0.5 ml. of tri-nbutylamine were added to the solution, which was then thoroughly agitated for dissolution.

2 ml. of pyridine containing 250 mg. of carbobenzyloxyglycine was then added to the reaction mixture. During 3 hours reaction, adenyl-5'-yl-carbobenzyl oxyglycine was synthesized in a yield of 32 percent.

What is claimed is:

1. A one-stage process for producing a nucleotide anhydride which comprises adding a member selected from the group consisting of diphenyl phosphorochloridate and tetraphenyl pyrophosphate to an alkylammonium salt of a nucleoside-S'-monophosphate in a reaction solvent selected from the group consisting of dioxane, dimethylformamide, and dimethylacetamide and in the presence of an alkylamine and adding to the resulting mixture an alkylammonium salt of an acid dissolved in pyridine or one of its derivatives whereby said anhydride is produced in a single stage without isolation of an intermediate.

2. A process for producing a nucleotide anhydride anhydride as claimed in claim 1 in which the quantities of the principal substances used therein in terms of multiples of the quantity in moles of said nucleoside-5-monophosphate are to 50 times of said dioxane, dimethylformamide or dimethylacetamide, l to 1.5 times of said diphenyl phosphorochloridate, 2 to 10 times of said acid, and 5 to 30 times of said pyridine solvent, and the process is carried out at a reaction temperature of from 0 to 30 C.

3. A process for producing nucleotide anhydride as claimed in claim 2 in which:

said alkyl-ammonium salt of a nucleoside-S'-monophosphate is selected from mono (methyl-tri-n-butylammonium)-5'- cytidylate,

mono (tri-n-butylammonium)5'-inosinate,

mono (tri-n-butylammonium) -5 -thymidylate,

mono (tri-n-butylammonium) -5 '-uridylate,

mono (methyl-tri-n-butylammonium) -5 adenylate,

mono (tri-n-octylammonium -5 '-adenylate,

mono methyktri-n-octylammonium) -5 cytidylate,

mono tri-n-octylammonium -5 -uridylate,

mono methyl-tri-n-butylammonium -5 adenylate, and

mono (tri-n-octyla'mmonium -5-adenylate;

and said alkyl-ammonium salt of an acid is selected from I mono (tri-n-butylammonium) phosphate,


mono (tri-n-butylammonium) glucose- 1- phosphate,

mono(methyl-tri-n-butylamrnonium)salt of flavine mononucleotide,

mono(methyl-tri-n-butylammonium)salt of flavine mononucleotide,

mono (methyl-tri-n-butylammonium) salt of o-phosphoethanolamine,

tri-n-butylammonium sulfate,

2,4-dinitrophenol, and


to produce, respectively, one of the compounds selected from trisodium cytidine-5'-diphosphate (CD'P Na trisodium inosine-5'-triphosphate (ITP Na trisodium thymidine-S'-triphosphate (TIP Na disodium uridine 5' diphosphoglucose (UDPG N32), adenosine-5'-diphosphoglucose (ADPG), fiavine-adenine-dinucleotide (FAD), CDP-ethanolamine, uridylyl sulfate, adenosine-S'-2,4-dinitrophenylphosphate, and adenyl- '-yl-carbobenzyl oxyglycine.

4. In a process for the preparation of a nucleotide anhydride by the steps of reacting a nucleoside-5-monophosphate with a reagent selected from a member of the group consisting of tetraphenyl pyrophosphate and diphenyl phosphorochloridate in the presence of a tertiary base and in a solvent, isolating and purifying the resultant P -nucleoside-5'-P -dipheny1 pyrophosphate, and then reacting said P -nucleoside-5'-P -diphenyl pyrophosphate with an acid having a weaker acidity than diphenyl phosphate to produce said anhydride, the improvement which comprises carrying out said preparation in a single stage without isolation and purification of said P -nucleoside- 5'-P -diphenyl pyrophosphate by mixing an alkylammonium salt of said nucleoside-5'-monophosphate with said reagent in a solvent which does not inhibit the reaction in the presence of an alkylamine and then adding directly to the resultant mixture an alkylammonium salt of said acid dissolved in pyridine or a pyridine derivative to form said anhydride.

References Cited UNITED STATES PATENTS 3,089,869 5/1963 Mauvernay 260--21l.5 R 3,299,043 1/ 1967 Schramm et al. 26021l.5 R 3,321,146 5/1967 Moifatt 260-2115 R 3,321,463 5/ 1967 Moflatt 260211.5 R

LEWIS GOTTS, Primary Examiner J. R. BROWN, Assistant Examiner US. Cl. X.R. 260-9'99

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3893998 *Feb 22, 1973Jul 8, 1975Univ IllinoisFluorescent derivatives of cytosine-containing compounds
US3960840 *Dec 29, 1972Jun 1, 1976University Of Illinois FoundatonFluorescent derivatives of adenine-containing compounds
US4816570 *Apr 4, 1986Mar 28, 1989The Board Of Regents Of The University Of Texas SystemBiologically reversible phosphate and phosphonate protective groups
US5401725 *Oct 25, 1993Mar 28, 1995Unitika Ltd.Treatment of tumors, rheumatoid arthritis and other diseases caused by vascular hyperplasia
US6303774 *Aug 20, 1999Oct 16, 2001Sri InternationalAntiviral agents, anticancer agents, metabolic moderators
US6613926Nov 1, 2000Sep 2, 2003Sri InternationalPerchloramido phosphonyl reagents and analogs thereof
U.S. Classification536/26.21, 536/26.26, 536/26.8, 536/26.25, 536/26.7, 536/26.74
International ClassificationC07H1/02, C07H19/20, C07H19/207, C07H19/10
Cooperative ClassificationC07H19/10, C07H1/02, C07H19/20
European ClassificationC07H19/10, C07H1/02, C07H19/20